Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Arcus Biosciences (RCUS) Accumulated Depreciation & Amortization (2017 - 2025)

Arcus Biosciences (RCUS) has 8 years of Accumulated Depreciation & Amortization data on record, last reported at $10.0 million in Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $10.0 million; the TTM value through Dec 2025 reached $10.0 million, changed N/A, while the annual FY2025 figure was $10.0 million, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization reached $10.0 million in Q4 2025 per RCUS's latest filing, up from $8.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $10.0 million in Q4 2025 and bottomed at $4.0 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 4 years is $7.0 million, with a median of $7.0 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 72.0% in 2021, then skyrocketed 50.0% in 2022.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $4.0 million in 2021, then surged by 50.0% to $6.0 million in 2022, then surged by 33.33% to $8.0 million in 2023, then grew by 25.0% to $10.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $10.0 million in Q4 2025, $8.0 million in Q4 2023, and $6.0 million in Q4 2022.